Redx Pharma Plc (LON:REDX - Get Free Report) insider Lisa Anson purchased 399,000 shares of the stock in a transaction on Thursday, April 11th. The stock was bought at an average price of GBX 8 ($0.10) per share, for a total transaction of £31,920 ($40,399.95).
Redx Pharma Stock Up 10.0 %
Shares of LON REDX opened at GBX 8.25 ($0.10) on Friday. Redx Pharma Plc has a 52-week low of GBX 4 ($0.05) and a 52-week high of GBX 37.90 ($0.48). The company has a debt-to-equity ratio of 527.00, a quick ratio of 1.93 and a current ratio of 1.11. The business has a fifty day moving average of GBX 17.42 and a two-hundred day moving average of GBX 21.47. The stock has a market cap of £32.09 million, a PE ratio of -79.00 and a beta of -0.53.
Redx Pharma Company Profile
(
Get Free Report)
Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating fibrotic disease, cancer, and the emerging area of cancer-associated fibrosis in the areas of unmet medical needs. The company also develops zelasudil (RXC007), a selective rho associated coiled-coil containing protein kinase 2 (ROCK2) inhibitor, which is in Phase 2 clinical trial for the treatment of multiple interstitial lung diseases and cancer-associated fibrosis; RXC008, a potential first-in-class GI-targeted ROCK inhibitor that is in preclinical studies for the treatment of fibrostenotic Crohn's disease; and zamaporvint (RXC004), a porcupine inhibitor that is in Phase 2 clinical trial for targeted therapy of Wnt-ligand dependent cancers.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
